{"id":13960,"date":"2021-12-06T15:27:40","date_gmt":"2021-12-06T14:27:40","guid":{"rendered":"https:\/\/actubusinessangels.com\/?p=13960"},"modified":"2021-12-06T15:27:40","modified_gmt":"2021-12-06T14:27:40","slug":"angels-sante-accompagne-la-startup-orixha","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/angels-sante-accompagne-la-startup-orixha\/","title":{"rendered":"Angels Sant\u00e9 accompagne la startup Orixha"},"content":{"rendered":"\n<p class=\"has-text-align-justify\"><strong><a href=\"https:\/\/orixha.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Orixha<\/a><\/strong> vise une premi\u00e8re mondiale : traiter des patients ayant subi un arr\u00eat cardiaque r\u00e9anim\u00e9 par ventilation liquidienne thermo-r\u00e9gul\u00e9. Elle annonce une lev\u00e9e de 2 millions d\u2019euros aupr\u00e8s d\u2019<strong><a href=\"https:\/\/www.angelssante.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Angels Sant\u00e9<\/a><\/strong>, d\u2019Erganeo et de ses partenaires industriels, InfiPlast, OEM Development et Activation. Ce tour d\u2019amor\u00e7age permet \u00e0 Orixha de d\u00e9velopper son dispositif m\u00e9dical Vent2Cool et ainsi r\u00e9aliser le premier essai clinique de cette technologie de ventilation liquidienne dans l\u2019arr\u00eat cardiaque.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p class=\"has-text-align-justify\"><strong>La n\u00e9cessit\u00e9 d\u2019apporter de nouvelles approches pour l\u2019arr\u00eat cardiaque r\u00e9anim\u00e9<br><\/strong>Aujourd\u2019hui, en Europe, l\u2019arr\u00eat cardiaque tue 9 personnes sur 10. Et ce, alors que le nombre de patients r\u00e9anim\u00e9s d\u2019un arr\u00eat cardiaque augmente gr\u00e2ce aux investissements en d\u00e9fibrillateurs, l\u2019implication des sauveteurs professionnels et du public pour prodiguer le massage cardiaque. Ainsi, sur 350.000 arr\u00eats cardiaques extra-hospitaliers par an, un tiers d\u2019entre eux sont d\u00e9sormais r\u00e9anim\u00e9s par les urgentistes et les patients arrivent vivants \u00e0 l\u2019h\u00f4pital. Malheureusement pour ces 120 000 patients r\u00e9anim\u00e9s en Europe chaque ann\u00e9e, deux tiers d\u2019entre eux d\u00e9c\u00e8dent \u00e0 l\u2019h\u00f4pital d\u2019une mort secondaire c\u00e9r\u00e9brale ou cardiaque li\u00e9e au Syndrome Post Arr\u00eat Cardiaque. Ce ph\u00e9nom\u00e8ne conduit finalement \u00e0 un taux de survie d\u2019environ 10%. Afin d\u2019am\u00e9liorer le pronostic neurologique, l\u2019une des strat\u00e9gies les plus efficaces consiste \u00e0 refroidir<br>les patients afin de les placer en hypothermie th\u00e9rapeutique (32 \u2013 33\u00b0C). Cependant, alors que les vertus protectrices de l\u2019hypothermie sont d\u00e9montr\u00e9es, les r\u00e9sultats de l\u2019\u00e9tude TTM2 publi\u00e9e en juin 2021 ont remis en cause l\u2019int\u00e9r\u00eat th\u00e9rapeutique de l\u2019hypothermie conventionnelle, qui ne permet de refroidir les patients qu\u2019apr\u00e8s 4 \u00e0 8 heures suivant r\u00e9animation, ce qui est trop tardif pour prot\u00e9ger efficacement les organes vitaux.<\/p>\n\n\n\n<p class=\"has-text-align-justify\"><strong>Orixha r\u00e9volutionne l\u2019induction de l\u2019hypothermie avec Vent2Cool<\/strong><br>Avec la solution Vent2Cool, Orixha utilise sa technologie de ventilation liquidienne propri\u00e9taire pour offrir une solution d\u2019induction ultra-rapide de l\u2019hypothermie th\u00e9rapeutique contre le Syndrome Post Arr\u00eat Cardiaque. Se servant des poumons comme \u00e9changeur thermique, Vent2Cool assure une courte ventilation thermo-r\u00e9gul\u00e9e du patient par un liquide respirable. Cela place les organes critiques du patient (cerveau, c\u0153ur, reins, etc.) en hypothermie th\u00e9rapeutique (32 \u2013 33\u00b0C) en moins de 15 minutes et permet par cons\u00e9quent de r\u00e9duire les d\u00e9c\u00e8s post r\u00e9animation de fa\u00e7on significative. La rapidit\u00e9 de cette induction prot\u00e8ge donc de la cascade inflammatoire cytokinique de reperfusion ainsi que des troubles m\u00e9taboliques pr\u00e9coces caus\u00e9s par le red\u00e9marrage du c\u0153ur.<br><em>\u00ab Vent2Cool induit un refroidissement des organes vitaux en seulement quelques minutes et non en<\/em> <em>quelques heures comme actuellement. Cette rapidit\u00e9 permet d\u2019agir sur l\u2019origine des s\u00e9quelles en bloquant les d\u00e9sordres inflammatoires et m\u00e9taboliques initiaux. Cela doit se traduire par plus de patients qui survivent \u00e0 un arr\u00eat cardiaque \u00bb<\/em> explique Professeur Renaud Tissier, co-fondateur d\u2019Orixha.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Une lev\u00e9e de fonds pour valider Vent2Cool en clinique, une premi\u00e8re mondiale<br>Fin 2020, Orixha a valid\u00e9 la performance et la s\u00e9curit\u00e9 du prototype industriel de Vent2Cool sur des mod\u00e8les in-vivo de r\u00e9f\u00e9rence. Cette lev\u00e9e de fonds, adoss\u00e9e \u00e0 des financements non-dilutifs, permettra le d\u00e9veloppement du dispositif m\u00e9dical et son utilisation sur les premiers patients pour valider la performance d\u2019hypothermie ultra-rapide de fa\u00e7on s\u00e9curis\u00e9e. <em>\u00ab Cette prochaine \u00e9tape, \u00e0 horizon 2023, n\u00e9cessitait de faire appel \u00e0 des investisseurs qui nous donnent les moyens de nos ambitions et apportent des comp\u00e9tences pr\u00e9cieuses au projet . Nous sommes ravis de voir que nos partenaires industriels et institutionnels participent \u00e0 cette lev\u00e9e de fonds, ce qui renforce l\u2019\u00e9cosyst\u00e8me du projet. Cette lev\u00e9e d\u00e9clenche par ailleurs des subventions et des pr\u00eats bancaires, et nous permet ainsi de mobiliser pr\u00e8s de 5M\u20ac sur cette phase critique du d\u00e9veloppement de Vent2Cool \u00bb<\/em> rel\u00e8ve Fabrice Paublant, Pr\u00e9sident d\u2019Orixha.<br>Le Dr Sophie Manuel, Business Angel chez Angels Sant\u00e9, ajoute \u00ab Nous avons \u00e9t\u00e9 s\u00e9duits par la compl\u00e9mentarit\u00e9 et l\u2019expertise de l\u2019\u00e9quipe Orixha au service d\u2019une innovation m\u00e9dicale qui devrait \u00eatre majeure. La solution qu\u2019ils d\u00e9veloppent r\u00e9pond \u00e0 un besoin m\u00e9dical tr\u00e8s fort de d\u00e9velopper des th\u00e9rapies plus efficaces pour la prise en charge de l\u2019arr\u00eat cardiaque. \u00bb Suat Topsu, Pr\u00e9sident d\u2019Erganeo, t\u00e9moigne :<em> \u00ab Nous sommes ravis de voir que Vent2Cool se rapproche de la clinique et va permettre de sauver des vies.<\/em> <em>Cette innovation de rupture est issue d\u2019une collaboration acad\u00e9mique entre l\u2019Universit\u00e9 de Sherbrooke,<\/em> <em>l\u2019INSERM et l\u2019Ecole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort, orchestr\u00e9e par Erganeo, qui a \u00e9galement d\u00e9pos\u00e9 deux brevets et financ\u00e9 un programme de maturation pour r\u00e9aliser la preuve de concept pr\u00e9clinique en 2018. \u00bb<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orixha vise une premi\u00e8re mondiale : traiter des patients ayant subi un arr\u00eat cardiaque r\u00e9anim\u00e9 par ventilation liquidienne thermo-r\u00e9gul\u00e9. Elle annonce une lev\u00e9e de 2 millions d\u2019euros aupr\u00e8s d\u2019Angels Sant\u00e9, d\u2019Erganeo et de ses partenaires industriels, InfiPlast, OEM Development et Activation. Ce tour d\u2019amor\u00e7age permet \u00e0 Orixha de d\u00e9velopper son dispositif m\u00e9dical Vent2Cool et ainsi&hellip;<\/p>\n","protected":false},"author":114,"featured_media":13968,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[155,85],"tags":[147,750],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.7.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Angels Sant\u00e9 accompagne la startup Orixha - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angels Sant\u00e9 accompagne la startup Orixha - France Angels\" \/>\n<meta property=\"og:description\" content=\"Orixha vise une premi\u00e8re mondiale : traiter des patients ayant subi un arr\u00eat cardiaque r\u00e9anim\u00e9 par ventilation liquidienne thermo-r\u00e9gul\u00e9. Elle annonce une lev\u00e9e de 2 millions d\u2019euros aupr\u00e8s d\u2019Angels Sant\u00e9, d\u2019Erganeo et de ses partenaires industriels, InfiPlast, OEM Development et Activation. Ce tour d\u2019amor\u00e7age permet \u00e0 Orixha de d\u00e9velopper son dispositif m\u00e9dical Vent2Cool et ainsi&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-06T14:27:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2021\/12\/orixha.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2481\" \/>\n\t<meta property=\"og:image:height\" content=\"1064\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Angels Sant\u00e9 accompagne la startup Orixha\",\"datePublished\":\"2021-12-06T14:27:40+00:00\",\"dateModified\":\"2021-12-06T14:27:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\"},\"wordCount\":847,\"commentCount\":842,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Angels Sant\u00e9\",\"Orixha\"],\"articleSection\":[\"2021\",\"Closing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\",\"name\":\"Angels Sant\u00e9 accompagne la startup Orixha - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2021-12-06T14:27:40+00:00\",\"dateModified\":\"2021-12-06T14:27:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Angels Sant\u00e9 accompagne la startup Orixha\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Angels Sant\u00e9 accompagne la startup Orixha - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/","og_locale":"en_US","og_type":"article","og_title":"Angels Sant\u00e9 accompagne la startup Orixha - France Angels","og_description":"Orixha vise une premi\u00e8re mondiale : traiter des patients ayant subi un arr\u00eat cardiaque r\u00e9anim\u00e9 par ventilation liquidienne thermo-r\u00e9gul\u00e9. Elle annonce une lev\u00e9e de 2 millions d\u2019euros aupr\u00e8s d\u2019Angels Sant\u00e9, d\u2019Erganeo et de ses partenaires industriels, InfiPlast, OEM Development et Activation. Ce tour d\u2019amor\u00e7age permet \u00e0 Orixha de d\u00e9velopper son dispositif m\u00e9dical Vent2Cool et ainsi&hellip;","og_url":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2021-12-06T14:27:40+00:00","og_image":[{"width":2481,"height":1064,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2021\/12\/orixha.png","type":"image\/png"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Angels Sant\u00e9 accompagne la startup Orixha","datePublished":"2021-12-06T14:27:40+00:00","dateModified":"2021-12-06T14:27:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/"},"wordCount":847,"commentCount":842,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Angels Sant\u00e9","Orixha"],"articleSection":["2021","Closing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/","url":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/","name":"Angels Sant\u00e9 accompagne la startup Orixha - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2021-12-06T14:27:40+00:00","dateModified":"2021-12-06T14:27:40+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-accompagne-la-startup-orixha\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Angels Sant\u00e9 accompagne la startup Orixha"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/13960"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=13960"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/13960\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/13968"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=13960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=13960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=13960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}